International Regulators Explain Work-Sharing Scheme For Biosimilars
Executive Summary
New guidance from the ACCESS Consortium of regulators from five countries explains how biosimilar drug sponsors can apply for an internationally-coordinated review of new products.
You may also be interested in...
Malaysia, Singapore Join Hands On Review Of Generic Drugs
The National Pharmaceutical Regulatory Agency and the Health Sciences Authority have announced a pilot to kick-off their new initiative on the simultaneous assessment of new generic drugs.
Malaysia, Singapore Join Hands On Review Of Generic Drugs
The National Pharmaceutical Regulatory Agency and the Health Sciences Authority have announced a pilot to kick-off their new initiative on the simultaneous assessment of new generic drugs.
International Regulator Consortium Eyes Real-World Data
The five-member ACCESS Consortium has outlined how it intends to build on its work-sharing experiences by applying innovative regulatory practices to the assessment of increasingly complex medicinal products.